Decisions, Decisions

With decreases in prices and efforts to sequence the genomes of more and more people, the University of Oxford's Michael Macklay writes at the Conversation that people will need to consider whether they want to know their risk of developing diseases like cancer and dementia.

"[B]efore you provide a saliva sample to have your own genetic recipe book read, it's important to know which results are worth knowing about," he says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.